Oscar Health (NYSE:OSCR) Shares Cross Below 200 Day Moving Average - Time to Sell?

Oscar Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Oscar Health shares slipped below their 200-day moving average of $24.72, trading as low as $24.55 and last at $24.68.
  • Analyst sentiment is mixed: the consensus rating is Hold, with an average price target of $34.60.
  • The latest quarter beat expectations, with EPS of $0.49 versus a forecast loss of $0.14 and revenue of $5.14 billion, up 72.1% year over year.
  • Five stocks we like better than Oscar Health.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) shares passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $24.72 and traded as low as $24.55. Oscar Health shares last traded at $24.68, with a volume of 6,598,842 shares.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on OSCR shares. Piper Sandler lowered their price objective on Oscar Health from $48.00 to $45.00 and set an "overweight" rating for the company in a research report on Friday, November 6th. UBS Group increased their price target on Oscar Health from $26.00 to $36.00 and gave the stock a "neutral" rating in a report on Monday, October 12th. Weiss Ratings cut Oscar Health from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Wednesday. Bank of America upped their price target on Oscar Health from $28.00 to $30.00 and gave the stock an "underperform" rating in a report on Thursday, September 17th. Finally, Wells Fargo & Company boosted their price objective on shares of Oscar Health from $20.00 to $27.00 and gave the company an "equal weight" rating in a research report on Thursday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $34.60.

Get Our Latest Stock Report on Oscar Health

Oscar Health Trading Down 5.7%

The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.16. The company has a 50-day simple moving average of $31.53 and a 200 day simple moving average of $24.72. The company has a market capitalization of $7.67 billion, a P/E ratio of 10.20, a P/E/G ratio of 0.24 and a beta of 2.56.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of ($0.14) by $0.63. The company had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $4.69 billion. Oscar Health had a net margin of 4.90% and a return on equity of 49.39%. The firm's revenue for the quarter was up 72.1% compared to the same quarter last year. During the same period last year, the firm earned ($0.53) EPS. Sell-side analysts expect that Oscar Health, Inc. will post 2.48 earnings per share for the current year.

Insiders Place Their Bets

In related news, CAO Victoria Baltrus sold 958 shares of the firm's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $30,129.10. Following the sale, the chief accounting officer owned 213,631 shares of the company's stock, valued at approximately $6,718,694.95. This trade represents a 0.45% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 31,422 shares of Oscar Health stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $988,221.90. Following the completion of the sale, the director directly owned 449,444 shares in the company, valued at approximately $14,135,013.80. This represents a 6.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 855,701 shares of company stock worth $26,166,546 over the last 90 days. 22.64% of the stock is currently owned by corporate insiders.

Institutional Trading of Oscar Health

Hedge funds have recently made changes to their positions in the company. Robinhood Markets Inc. acquired a new position in shares of Oscar Health during the 3rd quarter valued at $67,000. Regal Partners Ltd bought a new position in Oscar Health during the 3rd quarter worth approximately $1,036,000. Allworth Financial LP grew its position in shares of Oscar Health by 180.4% in the 3rd quarter. Allworth Financial LP now owns 5,694 shares of the company's stock worth $176,000 after buying an additional 3,663 shares during the last quarter. WCG Wealth Advisors LLC purchased a new position in shares of Oscar Health during the third quarter valued at approximately $321,000. Finally, Toronto Dominion Bank increased its holdings in Oscar Health by 1.0% in the 3rd quarter. Toronto Dominion Bank now owns 270,404 shares of the company's stock worth $8,339,000 after buying an additional 2,800 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

(Get Free Report)

Oscar Health is a U.S. health insurance company that uses technology and digital tools to connect members with health coverage and care. Founded in 2012, the company initially focused on individual health plans and has expanded its offerings to include coverage for small businesses. Oscar's products include individual and family plans, generally offered through the Affordable Care Act marketplaces, as well as small-group health insurance. Its services include a mobile app and online tools for managing benefits, finding care, and communicating with care teams.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines